HCKT
The Hackett Group, Inc.
HCKT has lower modeled downside risk, despite its lower overall score.
INTC
Intel Corporation
INTC has a slight edge over HCKT overall, supported by stronger fundamentals and stronger modeled upside.
HCKT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| Stable | |
| Stable |
HCKT's profitability is currently strong, and its cash flow and balance sheet are stable, but its revenue is under pressure.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
HCKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.7x | $13.44 | — |
| Cheap | 16x | $11.45 | -15% |
| Current | 19x | $13.44 | — |
| Fair | 21x | $14.55 | +8.2% |
| Expensive | 39x | $26.96 | +101% |
Historical ranges are pointers, not guarantees.
HCKT's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 8.7x next year's earnings, in its cheap range.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
HCKT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect HCKT's earnings to grow and its profitability to improve, with its revenue holding steady.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
INTC has the edge over HCKT on the outlook, with more favorable revenue expectations.
HCKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.55 | +121% |
| Q3 2026 | $0.70 | +84% |
| Q2 2026 | $0.65 | +8.3% |
| Q1 2026 | $0.53 | -38% |
| Q4 2025 | $0.47 | -56% |
| Q3 2025 | $0.38 | -69% |
| Q2 2025 | $0.60 | -52% |
| Q1 2025 | $0.85 | -33% |
| Q4 2024 | $1.06 | -15% |
HCKT has the edge over INTC on earnings quality, reporting a profit while its opponent remains loss making.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
HCKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $69.8M | -4.5% |
| Q2 2026 | $69.3M | -12% |
| Q1 2026 | $68.8M | -12% |
| Q4 2025 | $75.8M | -4.4% |
| Q3 2025 | $73.1M | -8.4% |
| Q2 2025 | $78.9M | +1.6% |
| Q1 2025 | $77.9M | +0.9% |
| Q4 2024 | $79.2M | +9.4% |
HCKT's revenue is shrinking: $70M last quarter, down 4.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.3 points |
| Q2 2026 | 11% | +5.3 points |
| Q1 2026 | 13% | +7.3 points |
| Q4 2025 | 12% | +2.2 points |
| Q3 2025 | 7.5% | -8.6 points |
| Q2 2025 | 5.8% | -10 points |
| Q1 2025 | 5.7% | -9.3 points |
| Q4 2024 | 9.8% | -6.1 points |
HCKT's operating margin was 11% last quarter, up 3.3 points from the same quarter a year ago.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC has the edge over HCKT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over HCKT on profitability, with a higher operating margin.
HCKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.3M | -115% |
| Q2 2026 | $12.6M | +237% |
| Q1 2026 | -$7.5M | -382% |
| Q4 2025 | $17.1M | -13% |
| Q3 2025 | $9M | -3.9% |
| Q2 2025 | $3.7M | -71% |
| Q1 2025 | $2.7M | +44% |
| Q4 2024 | $19.6M | -21% |
HCKT usually generates cash, though not every quarter: the latest was −$1M, but it generated $21M over the past year.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over HCKT on cash flow, with more consistent year-over-year improvement.
HCKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -213K shares |
| 1 year | -9.6% | -2.7M shares |
| 3 years | -10% | -2.9M shares |
| 5 years | -24% | -7.9M shares |
| Available history | -23% | -7.5M shares |
HCKT has the edge over INTC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.8M |
| Q2 2026 | $3.9M |
| Q1 2026 | $3M |
| Q4 2025 | $41.2M |
| Q3 2025 | $17.4M |
| Q2 2025 | $4.3M |
| Q1 2025 | $6.2M |
| Q4 2024 | $3.6M |
HCKT spent $50M buying back its own shares over the past year, up 58% from the year before.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has 5.3B diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
HCKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.0x | Moderate |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | -0.1x | Net Cash |
HCKT has the edge over INTC on leverage, with a lower net debt burden relative to earnings.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
HCKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.5 | Neutral |
| Stochastic | 84.5 | Overbought |
HCKT's weekly RSI is 60 (neutral) and its Stochastic is 84 (overbought).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
HCKT PE vs Technology Sector
| Metric | HCKT | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 28x | 31% below |
| PE % | 38 | 35 | 3 pts above |
HCKT is trading at 19x earnings, a 31% discount to the Technology sector's median of 28x.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
HCKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 13% above |
| 20 week MA | $11.2 | 20% above |
| 50 week MA | $13.3 | 1% above |
| 100 week MA | $19.0 | 29% below |
| 200 week MA | $21.0 | 36% below |
HCKT has the edge over INTC on trend strength, trading above more of its moving averages.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
HCKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.9 | $14.0 | -12% |
| 2021 | $14.0 | $20.7 | +47% |
| 2022 | $20.7 | $20.5 | -0.8% |
| 2023 | $20.5 | $22.8 | +11% |
| 2024 | $22.8 | $30.9 | +36% |
| 2025 | $30.9 | $20.0 | -35% |
| 2026 YTD | $20.0 | $13.4 | -33% |
HCKT has finished lower in three of the last six years. It's down 33% so far in 2026.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over HCKT on returns for 2026, with the stronger performance.